Mar 07, 2022 HealthTech - Shifting Landscapes Series (Part 1): Overview By Hannah Gardiner Eliza Saunders HealthTech: Trends and Challenges In a recent internal webinar, DLA Piper and Global Data looked into the shifting landscape of...
Jan 26, 2022 Initiative launched to accelerate EU clinical trials (ACT EU) By Lyndsey Hudson Accelerating Clinical Trials in the EU (ACT EU) was launched a few days ago, with the aim of transforming the way in which clinical...
Jan 25, 2022 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include significant updates to several...
Oct 05, 2021 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include the additions of Sweden and...
Sep 09, 2021 mRNA Technology: A New Approach to Therapeutics (podcast) By Lisa Haile For decades, scientists have studied the seemingly endless possibilities of custom-made messenger RNA, or mRNA. Kathy Fernando, Head Vice...
May 25, 2021 Launch of DLA Piper Global COVID-19 Vaccine Guide for Employers By Pilar Menor Marco de Morpurgo As the scientific response to the COVID-19 pandemic develops, many employers are considering what their approach should be to the issues...
May 11, 2021 EC's variations to the terms of marketing authorisations - another COVID-19 dictated reform By Mariana Ricardo As countries in the European Union (EU) take baby steps towards reopening businesses and ramp up COVID-19 vaccination, the pandemic and...
Feb 22, 2021 Portuguese VAT exemption to transfers of medical devices for in-vitro diagnosis of COVID-19, its vaccines and related provision of services By Inês Santana Metello Portugal published Law no. 4-C/2021, which transposes the Directive (EU) 2020/2020 from the 7th of December 2020, as regards temporary...
Feb 16, 2021 An ever-changing landscape - European regulator looks to speed up authorisation process for modified vaccines addressing COVID-19 variants By Kate Burgess At a time where drug makers are taking action to develop modified versions of their vaccines in order to address the evolving variants of...
Feb 10, 2021 The emergence of strategic assets in the health sector: Portugal takes the final step to create a National Medicines Laboratory By Mariana Ricardo Inês Santana Metello When the Covid-19 pandemic hit Europe in 2020, the Portuguese Government took the opportunity to establish the health sector as a...